Skip to main content

Table 1 Main characteristics of all studies included in the meta-analysis

From: Prognostic role of long non-coding RNA XIST expression in patients with solid tumors: a meta-analysis

First author

Year

Country

Cancer

Total number

LncRNA XIST expression

Detection method

Cut-off (high/low)

Multivariate analysis

Survival analysis

HR and 95% CI

High

Low

Chen

2016

China

GC

106

54

52

qRT-PCR

4.32

No

OS

Report

Song

2016

China

NPC

108

76

32

qRT-PCR

2.31-fold

No

OS

SC

Fang

2016

China

NSCLC

53

38

15

qRT-PCR

2.58-fold

Yes

OS

Report

Maa

2016

China

HCC

68

30

38

qRT-PCR

Mean

No

OS

SC

Kobayashi

2016

Japan

CSCC

49

24

25

qRT-PCR

Median

No

OS

SC

Mab

2016

China

GC

98

45

53

qRT-PCR

NA

No

OS

SC

Zhang

2017

China

Osteosarcoma

41

24

17

qRT-PCR

Median

No

OS

SC

Wu

2017

China

ESCC

127

64

63

qRT-PCR

Fold change

Yes

OS

Report

Hu

2017

China

Bladder

52

32

20

qRT-PCR

Fold change

No

OS

SC

Chen

2017

China

CRC

115

58

57

qRT-PCR

Median

Yes

OS

Report

Duc

2017

China

Glioma

69

35

34

qRT-PCR

Median

Yes

OS

Report

Wei

2017

China

PC

64

32

32

qRT-PCR

Median

Yes

OS

Report

Dud

2017

China

PCa

62

37

25

qRT-PCR

Mean

No

OS

SC

Li

2017

China

Osteosarcoma

145

75

70

qRT-PCR

NA

No

OS

SC

Kong

2017

China

HCC

52

26

26

qRT-PCR

Median

No

OS

SC

  1. HR, hazard ratio; 95% CI, 95% confidence interval; GC, gastric cancer; NPC, nasopharyngeal carcinoma; NSCLC, non-small cell lung cancer; HCC, hepatocellular carcinoma; CSCC, cervical squamous cell carcinoma; ESCC, esophageal squamous cell carcinoma; CRC, colorectal cancer; PC, pancreatic cancer; PCa, prostate cancer; qRT-PCR, quantitative reverse transcription PCR; NA, not available; OS, overall survival; SC, survival curve
  2. aWeijie Ma
  3. bLei Ma
  4. cPeng Du
  5. dYang Du